P006 Randomized Phase II trial evaluating three anti-diarrhoeal prophylaxis strategies in patients with HER2+/HR+ early breast cancer treated with extended adjuvant neratinib (DIANER GEICAM/2018-06)

Autor: González-Santiago, S., Gil-Gil, M., Carrasco, E., Martínez-Jáñez, N., Adamo, B., Antolín, S., Alonso, J.L., Vethencourt, A., Martínez-Vila, C., Galve, E., Rojo, F., Caballero, R., Casas, M., Cortazar, E., McCulloch, L., Vedovato, J.-C., Martín, M.
Zdroj: In The Breast April 2023 68 Supplement:S17-S17
Databáze: ScienceDirect
Externí odkaz: